Case Report| Volume 30, ISSUE 3, P431-434, June 2017

Download started.


Extramedullary Relapse of Acute Lymphoblastic Leukemia Presenting as Abnormal Uterine Bleeding: A Case Report

Published:January 03, 2017DOI:



      Acute lymphoblastic leukemia (ALL) is the most common childhood malignancy. Relapse of ALL occurs in 15%-20% of patients, with 2%-6% occurring exclusively in extramedullary sites. Relapse of ALL in gynecologic organs is extremely rare.


      We present a case of a 12-year-old girl with a history of ALL who was referred to the pediatric gynecology clinic with abnormal uterine bleeding. She was determined to have an extramedullary uterine relapse of her ALL.

      Summary and Conclusion

      Abnormal uterine bleeding in the setting of childhood malignancy is a frequent reason for consultation to pediatric and adolescent gynecology services. This bleeding is commonly attributed to thrombocytopenia due to bone marrow suppressive chemotherapeutic agents. However, as shown in this report, abnormal uterine bleeding might be a manifestation of an extramedullary relapse.

      Key Words

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


      Subscribe to Journal of Pediatric and Adolescent Gynecology
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect


        • Carroll W.L.
        • Raetz E.A.
        Clinical and laboratory biology of childhood acute lymphoblastic leukemia.
        J Pediatr. 2012; 160: 10
        • Kosucu P.
        • Kul S.
        • Gunes G.
        • et al.
        Multiple relapses in extramedullary localization of acute lymphoblastic leukemia.
        Bratisl Lek Listy. 2012; 113: 46
        • Cecalupo A.J.
        • Frankel L.S.
        • Sullivan M.P.
        Pelvic and ovarian extramedullary leukemic relapse in young girls: a report of four cases and review of the literature.
        Cancer. 1982; 50: 587
        • Parker C.
        • Waters R.
        • Leighton C.
        • et al.
        Effect of mitoxantrone on outcome of children with first relapse of acute lymphoblastic leukaemia (ALL R3): an open-label randomised trial.
        Lancet. 2010; 376: 2009
      1. ACOG committee opinion no. 651: menstruation in girls and adolescents: using the menstrual cycle as a vital sign.
        Obstet Gynecol. 2015; 126: e143
      2. Committee opinion no. 606: options for prevention and management of heavy menstrual bleeding in adolescent patients undergoing cancer treatment.
        Obstet Gynecol. 2014; 124: 397
      3. Practice bulletin no. 128: diagnosis of abnormal uterine bleeding in reproductive-aged women.
        Obstet Gynecol. 2012; 120: 197
        • Bresters D.
        • Emons J.A.
        • Nuri N.
        • et al.
        Ovarian insufficiency and pubertal development after hematopoietic stem cell transplantation in childhood.
        Pediatr Blood Cancer. 2014; 61: 2048
      4. Committee opinion no. 607: gynecologic concerns in children and adolescents with cancer.
        Obstet Gynecol. 2014; 124: 403
        • Chiodi S.
        • Spinelli S.
        • Bruzzi P.
        • et al.
        Menstrual patterns, fertility and main pregnancy outcomes after allogeneic haematopoietic stem cell transplantation.
        J Obstet Gynaecol. 2016; 36: 783
        • Couto-Silva A.C.
        • Trivin C.
        • Thibaud E.
        • et al.
        Factors affecting gonadal function after bone marrow transplantation during childhood.
        Bone Marrow Transplant. 2001; 28: 67
        • Maude S.L.
        • Teachey D.T.
        • Rheingold S.R.
        • et al.
        Sustained remissions with CD19-specific chimeric antigen receptor (CAR)-modified T cells in children with relapsed/refractory ALL (abstract 3011).
        J Clin Oncol. 2016; 34 (Available at: